Bone loss, pain and inflammation: three faces of ACPA in RA pathogenesis.
about
Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients.Bone mineral density in patients with psoriatic arthritis: data from the Nord-Trøndelag Health Study 3.Is osteoporosis an autoimmune mediated disorder?Association of Distinct Fine Specificities of Anti-Citrullinated Peptide Antibodies With Elevated Immune Responses to Prevotella intermedia in a Subgroup of Patients With Rheumatoid Arthritis and Periodontitis.
P2860
Bone loss, pain and inflammation: three faces of ACPA in RA pathogenesis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Bone loss, pain and inflammation: three faces of ACPA in RA pathogenesis.
@en
Bone loss, pain and inflammation: three faces of ACPA in RA pathogenesis.
@nl
type
label
Bone loss, pain and inflammation: three faces of ACPA in RA pathogenesis.
@en
Bone loss, pain and inflammation: three faces of ACPA in RA pathogenesis.
@nl
prefLabel
Bone loss, pain and inflammation: three faces of ACPA in RA pathogenesis.
@en
Bone loss, pain and inflammation: three faces of ACPA in RA pathogenesis.
@nl
P2860
P1476
Bone loss, pain and inflammation: three faces of ACPA in RA pathogenesis.
@en
P2093
David Pisetsky
Jeremy Sokolove
P2860
P304
P356
10.1136/ANNRHEUMDIS-2015-208308
P407
P577
2016-01-14T00:00:00Z